|
|||||
|
|

American firearms manufacturer Smith & Wesson (NASDAQ:SWBI) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 17.1% year on year to $135.7 million. Its non-GAAP profit of $0.08 per share was 60% above analysts’ consensus estimates.
Is now the time to buy SWBI? Find out in our full research report (it’s free for active Edge members).
Smith & Wesson’s latest quarter drew a positive market reaction, following results that outpaced Wall Street expectations. Management attributed the performance to higher average selling prices in handguns, a refreshed product lineup, and disciplined pricing strategies. CEO Mark Smith emphasized the company’s gains in market share, noting that increased shipments were supported by strong consumer demand and minimal reliance on promotional activity. The company also highlighted operational discipline, with inventory management and production alignment cited as contributors to improved margins and cash flow.
Looking ahead, management expects continued momentum from new product introductions and a stable market environment. CFO Deana McPherson outlined that further gross margin improvement is anticipated, driven by increased production and ongoing cost management. The company expects its assortment of higher-priced handguns and success in law enforcement channels to support growth. Mark Smith stated that a healthy sales pipeline and additional agency orders will be key to sustaining performance, with distributor feedback reinforcing confidence in demand trends.
Smith & Wesson’s management credited the quarter’s revenue and margin gains to strong handgun sales, higher average selling prices, and operational efficiency, while noting momentum in both consumer and law enforcement channels.
Smith & Wesson expects ongoing growth to be driven by new product launches, strong market positioning, and increased production to meet demand, while monitoring cost and inventory management.
Looking forward, our analysts will be focused on (1) the pace and breadth of new product adoption in both consumer and law enforcement channels, (2) management’s ability to execute on production scaling and maintain margin improvement, and (3) developments in the long gun strategy, particularly any moves to address market white space. Effective management of inventory and operational costs will also remain important signposts for future performance.
Smith & Wesson currently trades at $12.79, up from $11.79 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
| 8 hours | |
| 12 hours | |
| 21 hours | |
| 21 hours | |
| Mar-05 | |
| Mar-05 | |
| Mar-05 | |
| Mar-05 | |
| Mar-03 | |
| Feb-19 | |
| Feb-18 | |
| Feb-16 | |
| Feb-05 | |
| Feb-03 | |
| Feb-02 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite